Showing results (221-230 of 272) with videos related to

Sort By:
Pageof 28
Advances in Therapy|November 21, 2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary GroupNicola Fazio, Massimo Falconi, Emanuela Foglia, et al.
BMC Cancer|March 18, 2014
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT studyAlfredo Berruti, Nicola Fazio, Anna Ferrero, et al.
British Journal of Cancer|October 7, 2020
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancerMohammad Aarif Siddiqui, Paradesi Naidu Gollavilli, Vignesh Ramesh, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoidsDorian R A Swarts, Aldo Scarpa, Vincenzo Corbo, et al.
Endocrine Connections|October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancerFilomena Cetani, Chiara Banti, Elena Pardi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2017
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint InhibitorsAntonio Marchetti, Massimo Barberis, Renato Franco, et al.
Expert Review of Molecular Diagnostics|March 23, 2019
Recent advances in the molecular landscape of lung neuroendocrine tumorsGiuseppe Pelosi, Fabrizio Bianchi, Paul Hofman, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 17, 2021
IκBα targeting promotes oxidative stress-dependent cell deathGiovanna Carrà, Giuseppe Ermondi, Chiara Riganti, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2014
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional seriesLindsey Oudijk, Ronald R de Krijger, Ida Rapa, et al.
Neuroendocrinology|August 31, 2022
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT StudyPiero Ferolla, Alfredo Berruti, Francesca Spada, et al.
Pageof 28